FIELD: medicine, pharmacy. SUBSTANCE: invention claims thrombolytic agent activating fibrinolysis, the use of 6-amidino-2-naphthyl-4-[(4,5-dihydro-1H-imidazole- -2-yl)-amino]-benzoate or its pharmaceutically acceptable acid addition salts of the formula (I) as indicated agents and methods of treatment of patients with thrombosis and myocardium infarction. Agents showing thrombolytic and effect activating fibrinolysis have effective amount of the compound of the formula (I). Methods of patient treatment involve administration to patient an effective amount of an agent. Agents can contain pharmaceutically acceptable carriers additionally. The claimed agents and methods of patient treatment ensure to dissolve thrombi in blood vessels and so eliminate their obstruction. Agents can be administrated orally that makes advantages as compared with the known preparations of similar effect administrated into blood vessel by catheter. EFFECT: enhanced effectiveness of agents. 12 cl, 3 dwg, 2 tbl, 9 ex
Title |
Year |
Author |
Number |
THROMBOLYTICS FOR INTRAVASCULAR THROMBI |
2020 |
- Hong, Seong Tshool
- Kim, Hyeon Jin
- Hassan, Mdmehedi
|
RU2822136C1 |
DERMATAN SULFATE OR ITS SALT, ANTITHROMBOTIC AGENTS, METHOD OF PROPHYLAXIS AND TREATMENT OF THROMBOSIS, METHOD OF PROPHYLAXIS OR TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME, METHOD OF MYOCARDIUM INFARCTION TREATMENT |
1994 |
- Akikazu Takada
- Dzjuniti Onaja
- Mikio Arai
- Satosi Mijauti
- Mamoru Kiogasima
- Kejiti Esida
|
RU2153506C2 |
METHOD FOR TREATING HEMORRHAGES INTO INTERNAL MEDIA AND MEMBRANES OF AN EYE ACCOMPANIED WITH BLOOD PLATELETS HYPERAGGREGATION |
1998 |
- Mukha A.I.
- Filina A.A.
- Lysenko V.S.
|
RU2161020C2 |
PLASMINOGEN FOR TREATMENT AND PREVENTION OF MICROTHROMBOSIS |
2020 |
- Kiessig, Stephan T.
- Welz, Ricarda
- Gerding, Hanne Rieke
- Mazur, Marc
- Anders, Hans-Joachim
- Shi, Chongxu
- Schimmelpfennig, Christoph
- Devarapu, Satish Kumar
|
RU2813699C2 |
BIFUNCTIONAL VARIANT OF UROKINASE, PLASMID CONTAINING SYNTHETIC STRUCTURAL GENE ENCODING BIFUNCTIONAL UROKINASE, PLASMID (VARIANTS), METHOD OF PLASMID PREPARING, METHOD OF BIFUNCTIONAL VARIANT OF UROKINASE PREPARING, THROMBOLYTIC AGENT |
1994 |
- Gerd J. Shteffens
- Stefan Vnendt
- Jokhannes Shnajder
- Regina Khajntsel'-Viland
- Derek Dzhon Sonders
|
RU2143490C1 |
USE OF ICARITIN FOR OBTAINING MEDICINAL PRODUCTS |
2021 |
- Zhang Guimin
- Yao Jingchun
- Sun Chenghong
- Li Bin
- Pan Sina
|
RU2806093C1 |
THE PROLONGED THROMBOLYTIC AGENT AND A METHOD OF ITS PREPARING |
1995 |
- Ajsina Roza Bakirovna
- Varfolomeev Sergej Dmitrievich
|
RU2121362C1 |
DIHYDROINDOLYSINONE DERIVATIVE |
2015 |
- Tanaka Motoyuki
- Kondo Takasi
- Khiruka Yasuo
- Nisiyama Tajkhej
- Khiramatsu Atsusi
- Koda Tomoyuki
- Keuyama Se
|
RU2707887C2 |
COMPOUNDS AND COMPOSITIONS FOR TREATING OR PREVENTING PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESSIVE DEPOSITION OF FIBRIN AND/OR FORMATION OF THROMBI |
2015 |
- Jern Sverker
- Saljo Jonas Faijerson
- Bergh Niklas
|
RU2732761C2 |
METHOD OF PRODUCING AMIDINE DERIVATIVES |
0 |
- Setsuro Fudzi
- Tosiyuki Okutome
- Toeo Nakayama
- Takasi Yaegasi
- Masateru Kurumi
|
SU1176832A3 |